Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

University of Michigan

Status

Enrolling

Conditions

Inflammatory Bowel Diseases

Treatments

Device: Virtual reality-directed BGBT

Study type

Interventional

Funder types

Other

Identifiers

NCT06188793

HUM00240999

Details and patient eligibility

About

The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting.

The study hypothesizes that:

At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program
Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with Inflammatory Bowel Disease and self-reported pain
Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)

Exclusion criteria

Patients that do not report pain
Anticipated length of hospital stay is less than 72 hours
Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
Patients with binocular vision loss
Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
Patients that are currently pregnant